Azitra, Inc. (AZTR) vs Jupiter Neurosciences, Inc. (JUNS)

Azitra, Inc. and Jupiter Neurosciences, Inc. are both Biotechnology companies. Azitra, Inc. and Jupiter Neurosciences, Inc. are of similar size ($4.3M and $4.1M). Jupiter Neurosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Across the 8 metrics below, Azitra, Inc. leads on 6 and Jupiter Neurosciences, Inc. on 2.

Valuation

Metric AZTR JUNS Biotechnology median
P/E 1.05 n/m 8.50
P/S 2.33 n/m 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 n/m 0.64
EV/Sales (9.26) n/m 9.21
Earnings yield 95.57% (656.97%) (33.15%)
Free cash flow yield (842.70%) (446.77%) (25.50%)

Profitability

Metric AZTR JUNS Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (1,888.80%) (56.36%)
Return on assets (190.69%) (239.36%) (48.04%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR JUNS Biotechnology median
Revenue growth (TTM) 58.18% — 6.02%
EPS growth (last fiscal year) 85.67% (212.50%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AZTR JUNS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 0.66 4.72
Net debt to EBITDA 0.20 0.43 0.96

Dividend

Metric AZTR JUNS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR JUNS Biotechnology median
Market cap 4.33m 4.14m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack